Our keynote speaker on Monday 17th June will be Geert Molenberghs, Director of I-BioStat, Professor at Universiteit Hasselt KU Leuven.
He will give a talk about Biostatistics in a post-pandemic era: lessons learned for research, public health, drug and vaccine development, policy advice, and communication.
The keynote speaker on Tuesday 18th June will be Theo Smith, Founder of Neurodiversity World & Neuromine . ai, a Linkedin Top Voice, author of the award-winning book ‘Neurodiversity at Work' and podcast host of 'Neurodiversity with Theo Smith'.
He will give a talk and host a discussion on Neurodiversity at Work: Unleashing Potential in Every Mind.
On the afternoon of Sunday 16th June the PSI Training Committee and the PSI Scientific Committee are delighted to offer 2 pre-conference courses.
Pre-conference course 1: Bayesian methods for borrowing of information (with applications in clinical trials)
Pre-conference course 2: Applying causal inference for effective implementation of the estimand framework in drug development.
Read more about the Pre-Conference Courses here https://www.psiweb.org/conferences/pre-course-conferences.
Registration for both courses is available through the conference registration site. Places are limited so book early to avoid disappointment, and take advantage of the early bird discount!
This course is aimed at clinical trial statisticians who are new to or with limited experience of machine learning. Attendees will learn about a range of topics in machine learning, including practical sessions in R.
This webinar will explore two different approaches to Correlates of Protection in vaccine development.
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
The event will open with an overview on drug development in women’s health from a clinician perspective. This talk is followed by talks about statistical challenges when planning IVF studies and analysing the menstrual cycles.
This webinar will provide an overview of surrogacy for licensing and reimbursement. In turn, the need of extensions of the SPIRIT and CONSORT statement will be defined and outlined, with case studies to support.
Lea Vaas will present how replacement of concurrent control animals by Virtual Control Groups (VCGs) in systemic toxicity studies may help in contributing to the 3R's principle of animal experimentation: Reduce, Refine, Replace.
We will share a brief overview of what Mobilise D is and why it is an important step stone in the development of digital biomarkers, and how Mobilise D outputs can be relevant for you.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
An introductory course giving an overview of the pharmaceutical industry and the drug development process as a whole, aimed at those with 1-3 years' experience. It comprises of six 2-day sessions covering a range of topics including Research and Development, Toxicology, Data Management and the Role of a CRO, Clinical Trials, Reimbursement, and Marketing.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
We have exciting new opportunities available for Study Statisticians, Support Statisticians and Exploratory Statisticians at various levels.
